CURIS, INC. Share-based Payment Arrangement, Amount Capitalized
CURIS, INC. (CRIS) reported Share-based Payment Arrangement, Amount Capitalized of $822.58 thousand for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2012-11-06
- CURIS, INC. share-based payment arrangement, amount capitalized for the quarter ending 2012-09-30 was $822.58K, a 174.92% increase year-over-year.
- CURIS, INC. share-based payment arrangement, amount capitalized for the quarter ending 2012-06-30 was $833.50K, a 139.00% increase year-over-year.
- CURIS, INC. share-based payment arrangement, amount capitalized for the quarter ending 2011-09-30 was $299.20K.
- CURIS, INC. share-based payment arrangement, amount capitalized for the quarter ending 2011-06-30 was $348.74K.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 9 month |
|---|---|---|---|
| 2012-09-30 | $822.58K 10-Q · filed 2012-11-06 | $1.66M derived: sum of 2 quarters · filed 2012-11-06 | $2.47M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $833.50K 10-Q · filed 2012-08-09 | $1.65M 10-Q · filed 2012-08-09 | |
| 2011-09-30 | $299.20K 10-Q · filed 2012-11-06 | $647.94K derived: sum of 2 quarters · filed 2012-11-06 | $1.31M 10-Q · filed 2012-11-06 |
| 2011-06-30 | $348.74K 10-Q · filed 2012-08-09 | $1.01M 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |